Hutchinson, Geoffrey B.
Abiona, Olubukola M.
Ziwawo, Cynthia T. http://orcid.org/0000-0002-9772-8123
Werner, Anne P.
Ellis, Daniel
Tsybovsky, Yaroslav http://orcid.org/0000-0002-2159-5248
Leist, Sarah R. http://orcid.org/0000-0002-4989-5381
Palandjian, Charis
West, Ande
Fritch, Ethan J.
Wang, Nianshuang
Wrapp, Daniel
Boyoglu-Barnum, Seyhan
Ueda, George http://orcid.org/0000-0002-9792-7149
Baker, David http://orcid.org/0000-0001-7896-6217
Kanekiyo, Masaru http://orcid.org/0000-0001-5767-1532
McLellan, Jason S. http://orcid.org/0000-0003-3991-542X
Baric, Ralph S. http://orcid.org/0000-0001-6827-8701
King, Neil P. http://orcid.org/0000-0002-2978-4692
Graham, Barney S.
Corbett-Helaire, Kizzmekia S. http://orcid.org/0000-0002-2641-4688
Article History
Received: 24 October 2022
Accepted: 6 September 2023
First Online: 4 October 2023
Competing interests
: B.S.G., J.S.M., M.K., N.W., and K.S.C. are inventors on US Patent no. 10,960,070 entitled ‘Prefusion Coronavirus Spike Proteins and Their Use.’ K.S.C., O.M.A., G.B.H., N.W., D.W., J.S.M., and B.S.G. are inventors on US Patent Application No. 62/972,886 entitled “2019-nCoV Vaccine”. D.E., G.U., N.P.K., B.S.G., K.S.C., M.K., and G.B.H. are inventors on US patent application No. 63/022,214 entitled “Nanoparticle vaccines for coronaviruses”. N.P.K. is a co-founder, shareholder, paid consultant, and chair of the scientific advisory board of Icosavax, Inc. The King lab has received unrelated sponsored research agreements from Pfizer and GSK. All other authors declare no competing interests. All other authors declare no competing interests.